Targeted surgical parathyroidectomy in end ‐stage renal disease patients and long‐term metabolic control: A single‐center experience in the current era
Conclusion: Gland‐sparing PTX achieved acceptable control of ESRD‐associated hyperparathyroidism in most patients from a socioeconomically challenged, underserved population of the United States.
Source: Hemodialysis International - Category: Hematology Authors: Tibor F ülöp, Christian A. Koch, Abdeen R. Farah Musa, Christopher M. Clark, Kamel A. Gharaibeh, Zsolt Lengvársky, Mehrdad Hamrahian, Karen T. Pitman, Mehul P. Dixit Tags: Original Article Source Type: research
More News: Calcium | Dialysis | Hematology | Hemodialysis | Hormones | Hyperparathyroidism | Parathyroidectomy | Phosphorus | Sensipar | USA Health